The expression of p-AKT was significantly higher in HCC-827-PIK3CA-M cells than that in HCC-827 cells under the same dose of gefitinib, respectively (Fig. 1E, P < 0.05). This evidence concerns the gene PIK3CA and hepatocellular carcinoma.